Discovery of Wall Teichoic Acid Inhibitors as Potential Anti-MRSA beta-Lactam Combination Agents
H Wang, Terry Roemer(Merck Canada Inc. (Canada)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lei Liang, Todd A. Black(Merck & Co., Inc., Rahway, NJ, USA (United States)), TC Meredith, Jiangling Wu, JS Maria, Suzanne Walker(Harvard University), Debra McGuinness(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gill Cj, Amy Flattery(Merck & Co., Inc., Rahway, NJ, USA (United States)), Paul A. Mann(Merck & Co., Inc., Rahway, NJ, USA (United States)), Paul Zuck(Merck & Co., Inc., Rahway, NJ, USA (United States)), J Liu, Sang Hyub Lee(Seoul National University Hospital), Justin Y. Su(Stanford University), Xiaoyun She, Juan Pan, Judy Hailey(Merck & Co., Inc., Rahway, NJ, USA (United States)), CM Tan, Susan Kales(Jackson Laboratory)
Unknown
January 1, 2013
Cited by 16
Related Papers
Genomic Islands in the Pathogenic Filamentous Fungus Aspergillus fumigatus
|PLoS Genetics|2008|531
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419